Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients with Prima

 https://www.globenewswire.com/news-release/2020/02/20/1987666/0/en/Brickell-Biotech-Announces-Publication-of-its-U-S-Phase-2b-Study-Results-for-Sofpironium-Bromide-in-Patients-with-Primary-Axillary-Hyperhidrosis-in-the-Journal-of-the-American-Acad.html 

Mucha demanda en la preapertura

+80%